welcome
CNBC

CNBC

Health

Health

Hims & Hers shares rise as company adds new weight-loss medications to platform

CNBC
Summary
Nutrition label

83% Informative

Hims & Hers Health is adding Eli Lilly's weight loss medication Zepbound and diabetes drug Mounjaro .

The company's GLP-1 offerings have evolved as the company has contended with a volatile supply and regulatory environment.

With Tuesday 's rally, Hims and Hers shares are up about 27% in 2025 after soaring 172% last year .